Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

543 Views

234. COVID-19: Vaccines: Saturday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Vaccines

(2372) Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

A. Nagare, MBBS (he/him/his)

Director, clinical science
Gritstone bio, Inc
San Jose, California, United States

MD

M. Dhar, MBBS

Shandukani Research - Johannesburg (South Africa)
Johannesburg, Gauteng, South Africa
MM

M. Marrali, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
CP

Christine Palmer, PhD

Gritstone Bio
Cambridge, Massachusetts, United States
HV

Harshni Venkatraman, MS

Gritstone Bio
Cambridge, Massachusetts, United States
JJ

Jason Jaroslavsky, MS

Gritstone Bio
Cambridge, Massachusetts, United States
JK

JC Kuan, PhD

Gritstone Bio
Cambridge, Massachusetts, United States
LK

L. Kraemer, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
LA

L. Arcebuche, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
LH

L. Hernandez, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
Meghan Hart, ALM

Associate Director
Gritstone bio
Boston, Massachusetts, United States
SK

Sonia Kounlavouth, BS

Gritstone Bio
Cambridge, Massachusetts, United States
Pedro Garbes, MD

SVP, Clinical Development
Gritstone bio, Inc.
Weston, Massachusetts, United States
AA

A. Allen, MBBS, PhD

Gritstone bio, Inc
Emeryville, California, United States
KJ

Karin Jooss, PhD

Head of Research & Development
Gritstone bio, Inc.
Emeryville, California, United States
SM

Shabhir A. Mahdi, PhD

University of the Witwatersrand, Johannesburg, South Africa
Johannesburg, Gauteng, South Africa